Reliability of spot samples for assessment of urinary excretion of pyridinoline in patients with rheumatoid arthritis

被引:0
|
作者
Verhoeven, AC
Boers, M
Koppele, JMT
van der Laan, WH
de Roos, J
van der Linden, S
机构
[1] Free Univ Amsterdam Hosp, Dept Clin Epidemiol, NL-1007 MB Amsterdam, Netherlands
[2] Maastricht Univ Hosp, Internal Med Rheumatol Dept, Maastricht, Netherlands
[3] TNO, Prevent & Hlth, Vasc & Connect Tissue Res Div, Leiden, Netherlands
关键词
rheumatoid arthritis; pyridinoline; deoxypyridinoline; collagen crosslinks; urinary excretion; circadian rhythm;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine haw well a spot urine sample of patients with active rheumatoid arthritis (RA) can predict 24-hour urinary pyridinoline and deoxypyridinoline excretion Methods Urine samples of 11 hospitalized RA patients taken an 2 consecutive days at 8 a.m. and 4 p.m. were compared with samples from 24-hour collections (gold standard). High-performance liquid chromatography was used to measure the collagen crosslink concentrations. Results Sampling time was the only significant factor (repeated measurement ANOVA). Significant differences were found between morning and 24-hour samples and between morning and afternoon samples, but not between afternoon and 24-hour samples. Conclusions Samples collected in the afternoon (4 p.m) give the best approximation of 24-hour urinary pyridinoline excretion in patients with active rheumatoid arthritis. In longitudinal studies the sampling rime should be fixed.
引用
收藏
页码:78 / 80
页数:3
相关论文
共 50 条
  • [1] The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab
    Lidia Ostanek
    Andrzej Pawlik
    Iwona Brzosko
    Marek Brzosko
    Rozalia Sterna
    Marek Droździk
    Barbara Gawrońska-Szklarz
    [J]. Clinical Rheumatology, 2004, 23 : 214 - 217
  • [2] The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab
    Ostanek, L
    Pawlik, A
    Brzosko, I
    Brzosko, M
    Sterna, R
    Drozdzik, M
    Gawronska-Szklarz, B
    [J]. CLINICAL RHEUMATOLOGY, 2004, 23 (03) : 214 - 217
  • [3] URINARY EXCRETION OF ACID MUCOPOLYSACCHARIDES BY PATIENTS WITH RHEUMATOID ARTHRITIS
    DIFERRANTE, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (10): : 1516 - 1520
  • [4] Urinary excretion of thiol compounds in patients with rheumatoid arthritis
    Rojkovich, B
    Nagy, E
    Pröhle, T
    Poór, G
    Gergely, P
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (05) : 683 - 685
  • [5] Urinary excretion of nephrin in rheumatoid arthritis patients with proteinuria
    Oranskiy, S. P.
    Yeliseyeva, L. N.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : 572 - 574
  • [6] URINARY EXCRETION OF ACID MUCOPOLYSACCHARIDES BY PATIENTS WITH RHEUMATOID ARTHRITIS
    DIFERRANTE, N
    [J]. FEDERATION PROCEEDINGS, 1957, 16 (01) : 172 - 173
  • [7] LOW-DOSE DOXYCYCLINE INHIBITS PYRIDINOLINE EXCRETION IN SELECTED PATIENTS WITH RHEUMATOID-ARTHRITIS
    GREENWALD, RA
    MOAK, SA
    GOLUB, LM
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 419 - 421
  • [8] EXCRETION OF URINARY KININS IN RHEUMATOID ARTHRITIS
    JENSEN, KB
    RINVIK, SF
    DYRUD, OK
    [J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1965, 23 (2-3): : 231 - +
  • [9] URINARY PYRIDINOLINE AND DEOXYPYRIDINOLINE EXCRETION CORRELATE WITH DISEASE ACTIVITIES IN 1ST YEAR OF EARLY RHEUMATOID-ARTHRITIS
    GOUGH, A
    PEEL, N
    CALDWELL, T
    EASTELL, R
    EMERY, P
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 30 - 30
  • [10] EFFECT OF CYCLOSPORINE ON URINARY KALLIKREIN EXCRETION IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SPRAGG, J
    WEINBLATT, ME
    COBLYN, J
    FRASER, P
    AUSTEN, KF
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1988, 112 (03): : 324 - 332